Results 31 to 40 of about 8,124,451 (335)

A Novel Electrochemical Differentiation between Exosomal-RNA of Breast Cancer MCF7 and MCF7/ADR-Resistant Cells

Pharmaceuticals, 2023
Cancer is considered one of the most burdensome diseases affecting lives and, hence, the economy. Breast cancer is one of the most common types of cancer.
Mohammed H. Abdelaziz, Ehab N. El Sawy, Anwar Abdelnaser   +2 more
doaj   +1 more source

Skin Cancer Classification With Deep Learning: A Systematic Review

Frontiers in Oncology, 2022
Skin cancer is one of the most dangerous diseases in the world. Correctly classifying skin lesions at an early stage could aid clinical decision-making by providing an accurate disease diagnosis, potentially increasing the chances of cure before cancer ...
Yinhao Wu, B. Chen, An Zeng, Dan Pan, Ruixuan Wang, Shen Zhao   +5 more
semanticscholar   +1 more source

The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions

OncoImmunology, 2020
The consensus Immunoscore is a routine assay quantifying the adaptive immune response within the tumor microenvironment. It has a prognostic value that has been confirmed in a phase 3 clinical trial (NCCTG N0147) in stage III colon cancers.
Anastasia Lanzi, F. A. Sinicrope, A. B. Benson, Jérôme Galon   +3 more
doaj   +1 more source

Application and Performance of Artificial Intelligence (AI) in Oral Cancer Diagnosis and Prediction Using Histopathological Images: A Systematic Review

Biomedicines, 2023
Oral cancer (OC) is one of the most common forms of head and neck cancer and continues to have the lowest survival rates worldwide, even with advancements in research and therapy.
Sanjeev B. Khanagar, Lubna Alkadi, Maryam A. Alghilan, Sara Kalagi, Mohammed Awawdeh, Lalitytha Kumar Bijai, Satish Vishwanathaiah, Ali Aldhebaib, Oinam Gokulchandra Singh   +8 more
doaj   +1 more source

Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer

OncoImmunology, 2021
This review details the clinical utility of Immunoscore, measuring the immune response to cancer within the tumor microenvironment, in bladder cancer. Immunoscore was recently introduced into ESMO Clinical Practice Guidelines for gastrointestinal cancer ...
Elise F. Nassif, Constance Thibault, Stéphane Oudard, Jérôme Galon   +3 more
doaj   +1 more source

An improved transformer network for skin cancer classification

Comput. Biol. Medicine, 2022
BACKGROUND Use of artificial intelligence to identify dermoscopic images has brought major breakthroughs in recent years to the early diagnosis and early treatment of skin cancer, the incidence of which is increasing year by year worldwide and poses a ...
Chao Xin, Zhifang Liu, Keyu Zhao, Linlin Miao, Yizhao Ma, Xiaoxia Zhu, Qiongyan Zhou, Songting Wang, Lingzhi Li, Feng Yang, Suling Xu, Haijiang Chen   +11 more
semanticscholar   +1 more source

Cervix Type and Cervical Cancer Classification System Using Deep Learning Techniques

Medical devices, 2022
Purpose Cervical cancer is the 4th most common cancer among women, worldwide. Incidence and mortality rates are consistently increasing, especially in developing countries, due to the shortage of screening facilities, limited skilled professionals, and ...
Lidiya Wubshet Habtemariam, Elbetel Taye Zewde, G. Simegn   +2 more
semanticscholar   +1 more source

PLS dimension reduction for classification of microarray data [PDF]

, 2004
PLS dimension reduction is known to give good prediction accuracy in the context of classification with high-dimensional microarray data. In this paper, PLS is compared with some of the best state-of-the-art classification methods.
Boulesteix, Anne-Laure
core   +3 more sources

No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study

OncoImmunology, 2020
The multicenter international Society for Immunotherapy of Cancer (SITC) study of the consensus Immunoscore demonstrated the prediction of survival and response to chemotherapy in 763 Stage III colon cancer (CC) patients.
Paolo A. Ascierto, Francesco M. Marincola, Bernard A. Fox, Jérôme Galon   +3 more
doaj   +1 more source

Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods

Scientific Reports, 2021
Lung cancer is one of the deadliest cancers in the world. Two of the most common subtypes, lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), have drastically different biological signatures, yet they are often treated similarly and ...
Joe W. Chen, J. Dhahbi
semanticscholar   +1 more source